Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology

OBJECTIVES: Coronavirus disease 2019 (COVID-19) -associated pulmonary aspergillosis (CAPA) has emerged as a complication in critically ill COVID-19 patients. The objectives of this multinational study were to determine the prevalence of CAPA in patients with COVID-19 in intensive care units (ICU) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Prattes, Juergen, Wauters, Joost, Giacobbe, Daniele Roberto, Salmanton-García, Jon, Maertens, Johan, Bourgeois, Marc, Reynders, Marijke, Rutsaert, Lynn, Van Regenmortel, Niels, Lormans, Piet, Feys, Simon, Reisinger, Alexander Christian, Cornely, Oliver A., Lahmer, Tobias, Valerio, Maricela, Delhaes, Laurence, Jabeen, Kauser, Steinmann, Joerg, Chamula, Mathilde, Bassetti, Matteo, Hatzl, Stefan, Rautemaa-Richardson, Riina, Koehler, Philipp, Lagrou, Katrien, Hoenigl, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387556/
https://www.ncbi.nlm.nih.gov/pubmed/34454093
http://dx.doi.org/10.1016/j.cmi.2021.08.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387556/
https://www.ncbi.nlm.nih.gov/pubmed/34454093
http://dx.doi.org/10.1016/j.cmi.2021.08.014

Ejemplares similares